Clinical trial
Behavior Enhances Drug Reduction of Incontinence (BE-DRI)
NCT00090584 · Carelon Research, Other · Completed
Key facts
| NCT number | NCT00090584 |
|---|---|
| Title | Behavior Enhances Drug Reduction of Incontinence (BE-DRI) |
| Official title | Behavior Enhances Drug Reduction of Incontinence |
| Acronym | BE-DRI |
| Lead sponsor | Carelon Research, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Urinary Incontinence (UI) |
| Intervention type | Behavioral, Drug |
| Interventions | Tolterodine, Behavioral training |
| Enrollment | 307 |
| Start date | Aug 1, 2004 |
| Primary completion | Dec 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Aug 31, 2004 |
| Last update posted | Jun 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: